Bristol-Myers Squibb Company (BMY)
Bristol-Myers Squibb Company PE Ratio: 14.81
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
- Accounts Payable
- Accounts Receivable
- Accruals Pro
- Altman Z-Score Pro
- Asset Utilization
- Beneish M-Score Pro
- Beta Pro
- Book Value
- Book Value per Share
- Capital Expenditures
- Cash Conversion Cycle Pro
- Cash Div. Payout Ratio TTM Pro
- Cash Financing
- Cash Financing TTM
- Cash Investing
- Cash Investing TTM
- Cash Operations
- Cash Operations TTM
- Cash and Equivalents
- Cash and ST Investments
- Current Ratio
- Days Inventory Outstanding Pro
- Days Payable Outstanding Pro
- Days Sales Outstanding Pro
- Debt to Equity Ratio
- Dividend
- Dividend Yield
- EBITDA Margin TTM Pro
- EBITDA TTM Pro
- EV / EBIT Pro
- EV / EBITDA Pro
- EV / Free Cash Flow Pro
- EV / Revenues Pro
- Earnings Per Share
- Earnings Per Share Growth
- Earnings Per Share TTM
- Earnings Yield
- Effective Tax Rate TTM Pro
- Enterprise Value
- Expenses
- Expenses TTM
- Free Cash Flow
- Free Cash Flow TTM
- Free Cash Flow Yield Pro
- Fundamental Score Pro
- Gross Profit Margin
- Gross Profit TTM
- Income from Cont. Ops Pro
- Interest Expense
- Interest Income
- Inventories
- KZ Index Pro
- Liabilities
- Long Term Debt
- Market Cap
- Net Income
- Net Income TTM
- Net PP&E
- Operating Earnings Yield Pro
- Operating Margin TTM Pro
- Operating PE Ratio Pro
- Other Comprehensive Income Pro
- PE 10 Pro
- PE Ratio
- PE Value Pro
- PEG Ratio
- PS Value Pro
- Payout Ratio TTM Pro
- Price
- Price / Book Value
- Price / Sales Ratio
- Price / Tangible Book Value Pro
- Profit Margin
- R&D Expense
- Receivables Turnover
- Retained Earnings
- Retained Earnings Growth
- Return on Assets
- Return on Equity
- Return on Invested Capital Pro
- Revenue Growth
- Revenue Per Share TTM
- Revenues
- Revenues TTM
- SG&A Expense
- Shareholders Equity
- Shares Outstanding
- Stock Buybacks
- Tangible Book Value Pro
- Tangible Book Value Per Share Pro
- Tangible Common Equity Ratio Pro
- Times Interest Earned TTM Pro
- Total Assets
- Total Return Price
- Valuation (Historical Mult.) Pro
- Valuation Percentage Pro
- Value Score Pro
Select a metric
Date range:
to
<Embed Chart>
Pro Save as Image
Pro Data Export
Copy the code below and paste
into the embed destination.
into the embed destination.
Attention
OK
BMY PE Ratio Rankings
| Overall | 57th percentile | 1352 of 3168 |
| Sector | 64th percentile | 84 of 234 in Healthcare |
| Industry | 46th percentile | 8 of 15 in Drug Manufacturers - Major |
BMY PE Ratio Range, Past 5 Years
| Minimum | 4.543 | Jun 2010 |
| Maximum | 38.49 | Jun 2007 |
| Average | 14.31 |
About Price to Earnings Ratio
The price to earnings ratio (PE Ratio) is the measure of the share price relative to the annual net income earned by the firm per share. PE ratio shows current investor demand for a company share. A high PE ratio generally indicates increased demand because investors anticipate earnings growth in the future. The PE ratio has units of years, which can be interpreted as the number of years of earnings to pay back purchase price.
PE ratio is often referred to as the "multiple" because it demonstrates how much an investor is willing to pay for one dollar of earnings. PE Ratios are sometimes calculated using estimations of next year's earnings per share in the denominator. When this happens, it is usually noted.
Learn More
You may also be interested in these BMY related companies
BMY News
RT @ianestepan $CLDX if this data was from $BMY,$ONXX,$MDVN,$DNA or $PFE - people would be soooooo excited....
about a day ago by N0M0NEY_N0H0NEY
about a day ago by N0M0NEY_N0H0NEY
News related to $BMY, currently +0.5% since open: 'Bristol-Myers says FDA clears Mass. plant' http://stks.co/3q1B
about 10 days ago by TradeBot
about 10 days ago by TradeBot
Six Suitors Join $BMY in Considering a Bid for $AMLN http://stks.co/3psG
about 10 days ago by abubnic
about 10 days ago by abubnic
The Drama Continues At $AMLN: Takeover Still Likely. $BMY $LLY $SNY http://stks.co/3prL
about 10 days ago by abubnic
about 10 days ago by abubnic
Bristol-Myers (BMY) Announces FDA Approval of Devens, MA Plant for Manufacture of ORENCIA
May 15, 11:17AM Street Insider
May 15, 11:17AM Street Insider
U.S. FDA Approves Bristol-Myers Squibb Devens Biologics Manufacturing Facility
May 15, 11:01AM Benzinga
May 15, 11:01AM Benzinga
U.S. FDA Approves Bristol-Myers Squibb Devens Biologics Manufacturing Facility for Production of ORENCIA® (abatacept)
May 15, 11:00AM Business Wire
May 15, 11:00AM Business Wire
NR7 (EOD): Potential bullish NR7. Entry: 33.31. First Target: 34.00. $BMY http://chart.ly/qwxxeih
about 12 days ago by jackdamn
about 12 days ago by jackdamn
$BMY Ipilimumab,also known as MDX-010 or MDX-101 $DNDN Provenge along with $ARNA and $VVUS have been and are my Phamas for the next yr
about 14 days ago by selectstock
about 14 days ago by selectstock
Bristol-Myers Squibb to Present at Bank of America Merrill Lynch Health Care Conference
May 10, 11:00AM Business Wire
May 10, 11:00AM Business Wire
Huf Post: Two Drugs Harness Immune System To Fight Cancer. http://stks.co/3iDa $DNDN $BMY $AZN $ONTY $GSK
about 17 days ago by abubnic
about 17 days ago by abubnic
Listen to $BMY Bristol-Myers Squibb at Deutsche Bank AG Health Care Conference - live at 10:40 AM, ondemand after - http://stks.co/3hTs
about 18 days ago by earningscast
about 18 days ago by earningscast
@russwm thanks working hard here. above 34 is a desc trend break + above 10day. needs to hold 50day $BMY http://chart.ly/mghypbo
about 23 days ago by TraderNewburgh
about 23 days ago by TraderNewburgh
@TraderNewburgh I would love to hear your thoughts on $BMY in the short/medium term, if you have the time. Love your videos.
about 23 days ago by russwm
about 23 days ago by russwm
Listen to $BMY Bristol-Myers Squibb Annual Meeting of Stockholders - live at 10:00 AM, ondemand after - http://stks.co/3bIu
about 24 days ago by earningscast
about 24 days ago by earningscast
http://stks.co/3XIO Health Care Report Take A Look $FURX $BMY $AMLN
about 29 days ago by Stockmarketman2
about 29 days ago by Stockmarketman2
Listen to $BMY Q1 2012 earnings call - live at 10:30 AM, ondemand after - http://stks.co/3WpX
about 29 days ago by earningscast
about 29 days ago by earningscast
Recent Quotes
| Symbol | Price | Chg | Chg % | Market Cap |
|---|---|---|---|---|
| BMY | 32.99 | +0.47 | +1.45% | 54.88B |
| BMTI | 2.41 | +0.10 | +4.33% | 64.98M |
| BMRN | 38.51 | +0.47 | +1.24% | 4.398B |
| BMR | 18.42 | +0.05 | +0.27% | 2.833B |
| BLTI | 2.37 | +0.01 | +0.42% | 72.43M |
| BLL | 39.86 | +0.33 | +0.83% | 6.180B |
| BKSC | 11.37 | -0.63 | -5.25% | 50.60M |
| BKR | 22.62 | +0.09 | +0.40% | 214.94M |
| BKMU | 3.52 | +0.03 | +0.86% | 161.69M |
| BKK | 16.22 | +0.12 | +0.75% |